Location: Boston, MA
CIK: 0001816307 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value: $242M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Merus NV | 668,784 | $12.31M | 5.1% | $19.70 | — | EQUITIES | N5749R100 |
| MGNX | MacroGenics Inc | 1,361,809 | $9.764M | 4.0% | $5.66 | +6.4% | EQUITIES | 556099109 |
| VRAYQ | Viewray Inc | 2,793,748 | $9.666M | 4.0% | $3.87 | +9.3% | EQUITIES | 92672L107 |
| — | Poseida Therapeutics Inc | 2,689,301 | $8.283M | 3.4% | $3.66 | — | EQUITIES | 73730P108 |
| ORIC | Oric Pharmaceuticals Inc | 1,435,945 | $8.185M | 3.4% | $4.15 | +25.9% | EQUITIES | 68622P109 |
| TERN | Terns Pharmaceuticals Inc | 667,922 | $7.908M | 3.3% | $6.60 | +44.9% | EQUITIES | 880881107 |
| — | Akero Therapeutics Inc | 202,561 | $7.75M | 3.2% | $16.55 | — | EQUITIES | 00973Y108 |
| NUVL | Nuvalent Inc | 281,533 | $7.345M | 3.0% | $26.36 | +12.2% | EQUITIES | 670703107 |
| — | Bellus Health Inc | 1,000,000 | $7.2M | 3.0% | $7.01 | — | EQUITIES | 07987C204 |
| — | Intra-Cellular Therapies Inc | 125,035 | $6.771M | 2.8% | $49.08 | — | EQUITIES | 46116X101 |
| — | 89bio Inc | 438,215 | $6.674M | 2.8% | $15.23 | — | EQUITIES | 282559103 |
| VKTX | Viking Therapeutics Inc | 380,000 | $6.327M | 2.6% | $10.33 | 0.0% | EQUITIES | 92686J106 |
| COGT | Cogent Biosciences Inc | 579,264 | $6.25M | 2.6% | $11.29 | +13.3% | EQUITIES | 19240Q201 |
| — | Karyopharm Therapeutics Inc | 1,541,426 | $5.996M | 2.5% | $3.89 | — | EQUITIES | 48576U106 |
| KALV | KalVista Pharmaceuticals Inc | 723,544 | $5.687M | 2.3% | $7.46 | 0.0% | EQUITIES | 483497103 |
| SDGR | Schrodinger Inc | 212,825 | $5.604M | 2.3% | $22.22 | +6.9% | EQUITIES | 80810D103 |
| PLRX | Pliant Therapeutics, Inc | 199,600 | $5.309M | 2.2% | $19.20 | +48.3% | Call | 729139105 |
| ACRS | Aclaris Therapeutics, Inc | 651,400 | $5.27M | 2.2% | $15.96 | -20.5% | Call | 00461U105 |
| GILD | Gilead Sciences Inc | 60,130 | $4.989M | 2.1% | $71.32 | +4.7% | EQUITIES | 375558103 |
| BCRX | BioCryst Pharmaceuticals Inc | 577,757 | $4.818M | 2.0% | $11.39 | -15.5% | EQUITIES | 09058V103 |
| VCYT | Veracyte Inc | 209,653 | $4.675M | 1.9% | $30.58 | -21.0% | EQUITIES | 92337F107 |
| PHVS | Pharvaris NV | 559,387 | $4.506M | 1.9% | $8.17 | +7.8% | EQUITIES | N69605108 |
| — | ImmunoGen, Inc | 1,128,200 | $4.332M | 1.8% | $7.00 | — | Call | 45253H101 |
| UTHR | United Therapeutics Corp | 18,578 | $4.161M | 1.7% | $209.78 | +17.5% | EQUITIES | 91307C102 |
| VRTX | Vertex Pharmaceuticals Inc | 13,181 | $4.153M | 1.7% | $240.06 | +24.9% | EQUITIES | 92532F100 |
| REGN | Regeneron Pharmaceuticals Inc | 5,000 | $4.108M | 1.7% | $750.05 | 0.0% | EQUITIES | 75886F107 |
| XENE | Xenon Pharmaceuticals Inc | 96,643 | $3.459M | 1.4% | $29.63 | +24.7% | EQUITIES | 98420N105 |
| CERS | Cerus Corp | 1,152,902 | $3.424M | 1.4% | $5.67 | -46.9% | EQUITIES | 157085101 |
| BIIB | Biogen Idec Inc | 11,311 | $3.145M | 1.3% | $282.44 | -2.0% | EQUITIES | 09062X103 |
| — | 89bio, Inc | 200,000 | $3.046M | 1.3% | $15.23 | — | Call | 282559103 |
| CLDX | Celldex Therapeutics Inc | 84,651 | $3.046M | 1.3% | $40.09 | +7.6% | EQUITIES | 15117B202 |
| ALNY | Alnylam Pharmaceuticals Inc | 14,043 | $2.813M | 1.2% | $193.80 | +8.5% | EQUITIES | 02043Q107 |
| KRYS | Krystal Biotech Inc | 34,014 | $2.723M | 1.1% | $60.89 | +29.0% | EQUITIES | 501147102 |
| CGEM | Cullinan Oncology Inc | 265,032 | $2.711M | 1.1% | $11.40 | -3.3% | EQUITIES | 230031106 |
| PLRX | Pliant Therapeutics Inc | 100,000 | $2.66M | 1.1% | $19.20 | +48.3% | EQUITIES | 729139105 |
| MIRM | Mirum Pharmaceuticals Inc | 105,939 | $2.545M | 1.1% | $22.79 | 0.0% | EQUITIES | 604749101 |
| INCY | Incyte Corp | 33,938 | $2.453M | 1.0% | $78.23 | 0.0% | EQUITIES | 45337C102 |
| INSM | Insmed Inc | 143,794 | $2.452M | 1.0% | $27.01 | -28.1% | EQUITIES | 457669307 |
| PTGX | Protagonist Therapeutics Inc | 105,486 | $2.426M | 1.0% | $16.79 | 0.0% | EQUITIES | 74366E102 |
| MDGL | Madrigal Pharmaceuticals Inc | 10,000 | $2.423M | 1.0% | $97.80 | +178.6% | EQUITIES | 558868105 |
| VTYX | Ventyx Biosciences Inc | 70,000 | $2.345M | 1.0% | $38.88 | 0.0% | EQUITIES | 92332V107 |
| MLTX | MoonLake Immunotherapeutics | 105,750 | $2.262M | 0.9% | $16.81 | 0.0% | EQUITIES | 61559X104 |
| — | Mersana Therapeutics Inc | 540,059 | $2.22M | 0.9% | $5.05 | — | EQUITIES | 59045L106 |
| IMTX | Immatics Nv | 282,432 | $1.949M | 0.8% | $10.84 | -24.5% | EQUITIES | N44445109 |
| — | Morphic Holding Inc | 51,684 | $1.945M | 0.8% | $25.74 | — | EQUITIES | 61775R105 |
| ACRS | Aclaris Therapeutics Inc | 220,100 | $1.781M | 0.7% | $15.96 | -20.5% | EQUITIES | 00461U105 |
| ALT | Altimmune, Inc | 415,700 | $1.754M | 0.7% | $14.76 | -19.5% | Call | 02155H200 |
| TRVI | Trevi Therapeutics Inc | 885,924 | $1.639M | 0.7% | $3.14 | -28.0% | EQUITIES | 89532M101 |
| — | Prometheus Biosciences Inc | 13,921 | $1.494M | 0.6% | $110.00 | — | EQUITIES | 74349U108 |
| — | Point Biopharma Global Inc | 198,477 | $1.443M | 0.6% | $7.62 | — | EQUITIES | 730541109 |
| PHAT | Phathom Pharmaceuticals Inc | 200,000 | $1.428M | 0.6% | $8.78 | 0.0% | EQUITIES | 71722W107 |
| NTLA | Intellia Therapeutics Inc | 37,858 | $1.411M | 0.6% | $58.68 | -33.2% | EQUITIES | 45826J105 |
| CLYM | Eliem Therapeutics Inc | 485,955 | $1.409M | 0.6% | $4.97 | -30.8% | EQUITIES | 28658R106 |
| — | Seres Therapeutics Inc | 232,525 | $1.318M | 0.5% | $9.37 | — | EQUITIES | 81750R102 |
| SRPT | Sarepta Therapeutics Inc | 9,270 | $1.278M | 0.5% | $129.72 | 0.0% | EQUITIES | 803607100 |
| — | Astria Therapeutics Inc | 93,823 | $1.248M | 0.5% | $14.68 | — | EQUITIES | 04635X102 |
| CUE | Cue Biopharma Inc | 306,278 | $1.093M | 0.5% | $3.05 | +4.3% | EQUITIES | 22978P106 |
| — | Allakos Inc | 211,010 | $939K | 0.4% | $6.51 | — | EQUITIES | 01671P100 |
| VRDN | Viridian Therapeutics Inc | 36,381 | $926K | 0.4% | $31.32 | +2.4% | EQUITIES | 92790C104 |
| — | Jasper Therapeutics Inc | 500,000 | $905K | 0.4% | $1.81 | — | EQUITIES | 471871103 |
| BBIO | Bridgebio Pharma Inc | 40,000 | $663K | 0.3% | $11.66 | 0.0% | EQUITIES | 10806X102 |
| ABOS | Acumen Pharmaceuticals Inc | 146,922 | $597K | 0.2% | $5.74 | -8.9% | EQUITIES | 00509G209 |
| — | ImmunoGen Inc | 150,000 | $576K | 0.2% | $7.00 | — | EQUITIES | 45253H101 |
| TELA | Tela Bio Inc | 54,096 | $576K | 0.2% | $11.03 | 0.0% | EQUITIES | 872381108 |
| — | Aligos Therapeutics Inc | 631,887 | $552K | 0.2% | $0.87 | — | EQUITIES | 01626L105 |
| CVRX | Cvrx Inc | 30,000 | $280K | 0.1% | $6.00 | +120.5% | EQUITIES | 126638105 |
| GLUE | Monte Rosa Therapeutics Inc | 31,156 | $243K | 0.1% | $6.95 | 0.0% | EQUITIES | 61225M102 |
| — | LAVA Therapeutics NV | 140,291 | $233K | 0.1% | $4.57 | — | EQUITIES | N51517105 |
| CGEN | Compugen Ltd | 330,188 | $232K | 0.1% | $0.87 | -5.7% | EQUITIES | M25722105 |
| ELOX | Eloxx Pharmaceuticals Inc | 54,075 | $136K | 0.1% | $4.22 | -14.2% | EQUITIES | 29014R202 |
| RCKTW | Rocket Pharmaceuticals Inc | 104,828 | $11,531 | 0.0% | $0.11 | — | WARRANTS | 77313F114 |
| — | Fresh Tracks Therapeutics Inc | 10,000 | $6,600 | 0.0% | $1.50 | — | EQUITIES | 10802T204 |